An anonymous reader quotes a report from Ars Technica: Imagine working with special cameras that capture light your eyes can't even see -- ultraviolet rays that cause sunburn, infrared heat signatures that reveal hidden writing, or specific wavelengths that plants use for photosynthesis. Or perhaps using a special camera designed to distinguish the subtle visible differences that make paint colors appear just right under specific lighting. Scientists and engineers do this every day, and they're drowning in the resulting data. A new compression format called Spectral JPEG XL might finally solve this growing problem in scientific visualization and computer graphics. Researchers Alban Fichet and Christoph Peters of Intel Corporation detailed the format in a recent paper published in the Journal of Computer Graphics Techniques (JCGT). It tackles a serious bottleneck for industries working with these specialized images. These spectral files can contain 30, 100, or more data points per pixel, causing file sizes to balloon into multi-gigabyte territory -- making them unwieldy to store and analyze.

[...] The current standard format for storing this kind of data, OpenEXR, wasn't designed with these massive spectral requirements in mind. Even with built-in lossless compression methods like ZIP, the files remain unwieldy for practical work as these methods struggle with the large number of spectral channels. Spectral JPEG XL utilizes a technique used with human-visible images, a math trick called a discrete cosine transform (DCT), to make these massive files smaller. Instead of storing the exact light intensity at every single wavelength (which creates huge files), it transforms this information into a different form. [...]

According to the researchers, the massive file sizes of spectral images have reportedly been a real barrier to adoption in industries that would benefit from their accuracy. Smaller files mean faster transfer times, reduced storage costs, and the ability to work with these images more interactively without specialized hardware. The results reported by the researchers seem impressive -- with their technique, spectral image files shrink by 10 to 60 times compared to standard OpenEXR lossless compression, bringing them down to sizes comparable to regular high-quality photos. They also preserve key OpenEXR features like metadata and high dynamic range support. The report notes that broader adoption "hinges on the continued development and refinement of the software tools that handle JPEG XL encoding and decoding."

Some scientific applications may also see JPEG XL's lossy approach as a drawback. "Some researchers working with spectral data might readily accept the trade-off for the practical benefits of smaller files and faster processing," reports Ars. "Others handling particularly sensitive measurements might need to seek alternative methods of storage."

A breach of legacy Cerner servers at Oracle Health exposed patient data from multiple U.S. hospitals and healthcare organizations, with threat actors using compromised customer credentials to steal the data before it had been migrated to Oracle Cloud. Despite confirming the breach privately, Oracle Health has yet to publicly acknowledge the incident. BleepingComputer reports: Oracle Health, formerly known as Cerner, is a healthcare software-as-a-service (SaaS) company offering Electronic Health Records (EHR) and business operations systems to hospitals and healthcare organizations. After being acquired by Oracle in 2022, Cerner was merged into Oracle Health, with its systems migrated to Oracle Cloud. In a notice sent to impacted customers and seen by BleepingComputer, Oracle Health said it became aware of a breach of legacy Cerner data migration servers on February 20, 2025.

"We are writing to inform you that, on or around February 20, 2025, we became aware of a cybersecurity event involving unauthorized access to some amount of your Cerner data that was on an old legacy server not yet migrated to the Oracle Cloud," reads a notification sent to impacted Oracle Health customers. Oracle says that the threat actor used compromised customer credentials to breach the servers sometime after January 22, 2025, and copied data to a remote server. This stolen data "may" have included patient information from electronic health records. However, multiple sources told BleepingComputer that it was confirmed that patient data was stolen during the attack.

Oracle Health is also telling hospitals that they will not notify patients directly and that it is their responsibility to determine if the stolen data violates HIPAA laws and whether they are required to send notifications. However, the company says they will help identify impacted individuals and provide templates to help with notifications.

An anonymous reader shares a report: New data recently released by the Environmental Protection Agency indicate that more than 158 million people across the U.S. have drinking water contaminated by toxic "forever chemicals," scientifically known as perfluoroalkyl and polyfluoroalkyl substances (PFAS).

"Drinking water is a major source of PFAS exposure. The sheer number of contaminated sites shows that these chemicals are likely present in most of the U.S. water supply," said David Andrews, deputy director of investigations and a senior scientist at the Environmental Working Group (EWG), a nonprofit advocacy organization, in a recent press release.

Stanford University researchers have proposed creating "bodyoids" -- ethically sourced human bodies grown from stem cells without neural components for consciousness or pain sensation -- to revolutionize medical research and address organ shortages. In a new opinion piece published in MIT Technology Review, scientists Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi argue that recent advances in biotechnology make this concept increasingly plausible. The approach would combine pluripotent stem cells, artificial uterus technology, and genetic techniques to inhibit brain development.

The researchers point to persistent shortages of human biological materials as a major bottleneck in medical progress. More than 100,000 patients currently await solid organ transplants in the US alone, while less than 15% of drugs entering clinical trials receive regulatory approval. These lab-grown bodies could potentially generate patient-specific organs that are perfect immunological matches, eliminate the need for lifelong immunosuppression, and provide personalized drug screening models.

A Nature survey has found that three-quarters of responding U.S. scientists are considering leaving the nation following disruptions to science under the Trump administration.

Out of 1,608 respondents, 75.3% said they were contemplating leaving the country. Scientists cited concerns over research funding and the general treatment of science as contributing factors for their reasoning. Europe and Canada were mentioned as potential destinations for those looking for opportunities abroad.

As NASA faces potential budget cuts, China is unveiling an ambitious series of deep space missions -- including Mars sample returns, outer planet exploration, and a future Mars base. While some of China's plans are aspirational, their track record of successful missions lends credibility to their expanding role in space. Ars Technica reports: China created a new entity called the "Deep Space Exploration Laboratory" three years ago to strengthen the country's approach to exploring the Solar System. Located in eastern China, not far from Shanghai, the new laboratory represented a partnership between China's national space agency and a local public college, the University of Science and Technology of China.

Not much is known outside of China about the laboratory, but it has recently revealed some very ambitious plans to explore the Solar System, including the outer planets. This week, as part of a presentation, Chinese officials shared some public dates about future missions. Space journalist Andrew Jones, who tracks China's space program, shared some images with a few details. Among the planned missions are:

- 2028: Tianwen-3 mission to collect samples of Martian soil and rocks and return them to Earth
- 2029: Tianwen-4 mission to explore Jupiter and its moon Callisto
- 2030: Development of a large, ground-based habitat to simulate long-duration human spaceflight
- 2033: Mission to Venus that will return samples of its atmosphere to Earth
- 2038: Establishment of an autonomous Mars research station to study in-situ resource utilization
- 2039: Mission to Triton, Neptune's largest moon, with a subsurface explorer for its ocean

Paul Ginsparg, a physics professor at Cornell University, created arXiv nearly 35 years ago as a digital repository where researchers could share their findings before peer review. Today, the platform hosts more than 2.6 million papers, receives 20,000 new submissions monthly, and serves 5 million active users, Wired writes in a profile of the platform.

"Just when I thought I was out, they pull me back in!" Ginsparg quotes from The Godfather, reflecting his inability to fully hand over the platform despite numerous attempts. If arXiv stopped functioning, scientists worldwide would face immediate disruption. "Everybody in math and physics uses it," says Scott Aaronson, a computer scientist at the University of Texas at Austin. "I scan it every night."

ArXiv revolutionized academic publishing, previously dominated by for-profit giants like Elsevier and Springer, by allowing instant and free access to research. Many significant discoveries, including the "transformers" paper that launched the modern AI boom, first appeared on the platform. Initially a collection of shell scripts on Ginsparg's NeXT machine in 1991, arXiv followed him from Los Alamos National Laboratory to Cornell, where it found an institutional home despite administrative challenges. Recent funding from the Simons Foundation has enabled a hiring spree and long-needed technical updates.

The U.S. Space Force has certified United Launch Alliance's Vulcan Centaur rocket for national security missions after successful test flights and resolution of a booster nozzle issue. This certification allows ULA to join SpaceX in conducting launches under the National Security Space Launch program, with Vulcan missions expected to begin this summer. SpaceNews reports: "Thank you to all our customer partners who have worked hand-in-hand with us throughout this comprehensive certification process. We are grateful for the collaboration and excited to reach this critical milestone in Vulcan development," said Tory Bruno, president and chief executive of United Launch Alliance in a ULA statement about the vehicle's certification.

Bruno said at the roundtable that the next launch by ULA will be of its Atlas 5, carrying a set of Project Kuiper broadband satellites for Amazon. That launch is expected as soon as next month. He said then that would be followed by the first two Vulcan national security launches, missions designated USSF-106 and USSF-87. ULA did not give a schedule for those upcoming Vulcan launches but Space Systems Command, in a summary accompanying its press release, said the first NSSL mission on Vulcan is planned for the summer. Bruno said at the roundtable that the payloads for those missions have "complex processing" requirements beyond a typical mission, and did not state how long it would take them to be ready for a launch.

Bruno said ULA is projecting a dozen launches this year, split roughly evenly between Atlas and Vulcan and between national security and commercial missions. ULA has been stockpiling components, such as BE-4 engines and solid rocket boosters, needed for those missions. "We're all staged up and ready, and as spacecraft show up, we'll be able to fly them," he said. He noted the company wants to get to a "baseline tempo" of two launches a month by the end of this year and perform 20 launches next year.

Scientists in China successfully transplanted a genetically modified pig liver into a brain-dead patient, where it functioned for 10 days. The liver, modified to reduce immune rejection, produced key proteins and bile, showing compatibility and offering hope for future short-term xenotransplants. The Guardian reports: The surgery, at a Chinese hospital last year, is thought to mark the first time a pig liver has been transplanted into a human. It raises the prospect of pig livers serving as a "bridging organ" for patients on the waiting list for a transplant or to support liver function while their own organ regenerates. [...] The latest procedure was carried out in a 50-year-old man diagnosed with brain death after a severe head injury. The patient's own liver was intact and, in a surgery that took more than 10 hours, the organ taken from a genetically modified Bama miniature pig was plumbed into his blood supply as an additional liver.

The pig had six genetic modifications aimed at preventing immune rejection. These included deactivating genes that contribute to the production of sugars on the surface of pig cells, which the human immune system attacks, and introducing genes that express human proteins to "humanize" the liver. After the transplant, the pig liver showed signs of functioning, including producing bile, which helps break down fats in the digestive system, and porcine albumin, a blood protein. The team behind the advance, described in the journal Nature, said it was not clear whether the liver would have been able to fully support the patient, given that he had an existing liver and because the liver was removed after 10 days at the request of his family.

sciencehabit quotes a report from Science.org: Whales sing, orcas squeal, and sea turtles croak. But sharks are more the strong, silent type. Now, researchers report the first evidence that sharks make sounds, too, described today in Royal Society Open Science. The animals may be making the sounds -- a series of clicking noises -- by snapping their flat rows of teeth, which are blunt for crushing prey. The sharks can hear mostly low-frequency noise, and the clicks they emit are higher pitched, which suggests they are not for communicating with other rigs. It's possible they are a defensive tactic. Marine mammals that eat rigs, such as leopard seals, can hear in the frequency range of the rig clicks, but the researchers question whether a few clicks would deter an attack. The sounds might be part of their response to being startled, the team says.

JPMorgan Chase used a quantum computer from Honeywell's Quantinuum to generate and mathematically certify truly random numbers -- an advancement that could significantly enhance encryption, security, and financial applications. The breakthrough was validated with help from U.S. national laboratories and has been published in the journal Nature. From a report: Between May 2023 and May 2024, cryptographers at JPMorgan wrote an algorithm for a quantum computer to generate random numbers, which they ran on Quantinuum's machine. The US Department of Energy's supercomputers were then used to test whether the output was truly random. "It's a breakthrough result," project lead and Head of Global Technology Applied Research at JPMorgan, Marco Pistoia told Bloomberg in an interview. "The next step will be to understand where we can apply it."

Applications could ultimately include more energy-efficient cryptocurrency, online gambling, and any other activity hinging on complete randomness, such as deciding which precincts to audit in elections.

An anonymous reader quotes a report from Gizmodo: Scientists scrutinizing the seafloor beneath a calving iceberg found a remarkable array of living creatures, switching up notions of how the giant chunks of ice affect their immediate environs. The scientists investigated a region of seafloor recently exposed by the calving of a gigantic iceberg -- A-84 -- which is as large as Chicago. The team found a surprisingly vibrant community of critters on the seafloor below where A-84 was once attached to an ice shelf attached to Antarctica.

Without the 197-square-mile (510-square-kilometer) iceberg in the way, the team was able to scrutinize the seafloor at depths of 4,265 feet (1,300 meters) using the remotely operated vehicle (ROV) SuBastian. The team found large corals and sponges supporting other lifeforms, including icefish, giant sea spiders, and octopus. [...] With the icebergs covering the seafloor, organisms below the shelf cannot get nutrients for survival from the surface. The team hypothesized that ocean currents are a critical driver for life beneath the ice sheets. The team also collected data on the larger ice sheet, whose shrinking size spells concern for the animals that live beneath it.

In an op-ed for MIT Technology Review, authors Carsten T. Charlesworth, Henry T. Greely, and Hiromitsu Nakauchi make the case for human "bodyoids" that could reduce animal testing, improve drug development, and alleviate organ shortages: Why do we hear about medical breakthroughs in mice, but rarely see them translate into cures for human disease? Why do so few drugs that enter clinical trials receive regulatory approval? And why is the waiting list for organ transplantation so long? These challenges stem in large part from a common root cause: a severe shortage of ethically sourced human bodies. It may be disturbing to characterize human bodies in such commodifying terms, but the unavoidable reality is that human biological materials are an essential commodity in medicine, and persistent shortages of these materials create a major bottleneck to progress.

This imbalance between supply and demand is the underlying cause of the organ shortage crisis, with more than 100,000 patients currently waiting for a solid organ transplant in the US alone. It also forces us to rely heavily on animals in medical research, a practice that can't replicate major aspects of human physiology and makes it necessary to inflict harm on sentient creatures. In addition, the safety and efficacy of any experimental drug must still be confirmed in clinical trials on living human bodies. These costly trials risk harm to patients, can take a decade or longer to complete, and make it through to approval less than 15% of the time.

There might be a way to get out of this moral and scientific deadlock. Recent advances in biotechnology now provide a pathway to producing living human bodies without the neural components that allow us to think, be aware, or feel pain. Many will find this possibility disturbing, but if researchers and policymakers can find a way to pull these technologies together, we may one day be able to create "spare" bodies, both human and nonhuman. These could revolutionize medical research and drug development, greatly reducing the need for animal testing, rescuing many people from organ transplant lists, and allowing us to produce more effective drugs and treatments. All without crossing most people's ethical lines.

Although it may seem like science fiction, recent technological progress has pushed this concept into the realm of plausibility. Pluripotent stem cells, one of the earliest cell types to form during development, can give rise to every type of cell in the adult body. Recently, researchers have used these stem cells to create structures that seem to mimic the early development of actual human embryos. At the same time, artificial uterus technology is rapidly advancing, and other pathways may be opening to allow for the development of fetuses outside of the body. Such technologies, together with established genetic techniques to inhibit brain development, make it possible to envision the creation of "bodyoids" -- a potentially unlimited source of human bodies, developed entirely outside of a human body from stem cells, that lack sentience or the ability to feel pain.

Firefly Aerospace has teamed up with Blue Origin's Honeybee Robotics unit to deploy a rover on its 2028 lunar mission to study the Gruithuisen Domes -- rare volcanic formations that may reveal insights into the moon's geology and potential resources. The announcement follows Firefly's successful Blue Ghost Mission 1, which outlasted all prior commercial lunar landings. Reuters reports: The Gruithuisen Domes, located on the moon's near side, are unusual volcanic formations believed to be rich in silica -- a composition rare on the lunar surface -- and studying them could unlock clues about the moon's geological history and potential resources for future human missions. [...] The upcoming mission, part of NASA's Commercial Lunar Payload Services initiative, will use Firefly's Blue Ghost lander and Elytra Dark orbital vehicle, alongside the Honeybee Robotics rover, to explore the domes, building on the success of its debut effort, Firefly said.

NASA's Curiosity rover has detected the largest organic molecules ever found on Mars -- decane, undecane, and dodecane -- suggesting that complex prebiotic chemistry may have occurred in the planet's ancient lakebeds. The findings have been published in the Proceedings of the National Academy of Sciences. From a press release: Scientists probed an existing rock sample inside Curiosity's Sample Analysis at Mars (SAM) mini-lab and found the molecules decane, undecane, and dodecane. These compounds, which are made up of 10, 11, and 12 carbons, respectively, are thought to be the fragments of fatty acids that were preserved in the sample. Fatty acids are among the organic molecules that on Earth are chemical building blocks of life. Living things produce fatty acids to help form cell membranes and perform various other functions. But fatty acids also can be made without life, through chemical reactions triggered by various geological processes, including the interaction of water with minerals in hydrothermal vents.

While there's no way to confirm the source of the molecules identified, finding them at all is exciting for Curiosity's science team for a couple of reasons. Curiosity scientists had previously discovered small, simple organic molecules on Mars, but finding these larger compounds provides the first evidence that organic chemistry advanced toward the kind of complexity required for an origin of life on Mars. The new study also increases the chances that large organic molecules that can be made only in the presence of life, known as "biosignatures," could be preserved on Mars, allaying concerns that such compounds get destroyed after tens of millions of years of exposure to intense radiation and oxidation.

An anonymous reader quotes a report from 404 Media: 23andMe filed for Chapter 11 bankruptcy Sunday, leaving the fate of millions of people's genetic information up in the air as the company deals with the legal and financial fallout of not properly protecting that genetic information in the first place. The filing shows how dangerous it is to provide your DNA directly to a large, for-profit commercial genetic database; 23andMe is now looking for a buyer to pull it out of bankruptcy. 23andMe said in court documents viewed by 404 Media that since hackers obtained personal data about seven million of its customers in October 2023, including, in some cases "health-related information based upon the user's genetics," it has faced "over 50 class action and state court lawsuits," and that "approximately 35,000 claimants have initiated, filed, or threatened to commence arbitration claims against the company." It is seeking bankruptcy protection in part to simplify the fallout of these legal cases, and because it believes it may not have money to pay for the potential damages associated with these cases.

CEO and cofounder Anne Wojcicki announced she is leaving the company as part of this process. The company has the genetic data of more than 15 million customers. According to its Chapter 11 filing, 23andMe owes money to a host of pharmaceutical companies, pharmacies, artificial intelligence companies (including a company called Aganitha AI and Coreweave), as well as health insurance companies and marketing companies. Shortly before the filing, California Attorney General Rob Bonta issued an "urgent" alert to 23andMe customers: "Given 23andMe's reported financial distress, I remind Californians to consider invoking their rights and directing 23andMe to delete their data and destroy any samples of genetic material held by the company."

In a letter to customers Sunday, 23andMe said: "Your data remains protected. The Chapter 11 filing does not change how we store, manage, or protect customer data. Our users' privacy and data are important considerations in any transaction, and we remain committed to our users' privacy and to being transparent with our customers about how their data is managed." It added that any buyer will have to "comply with applicable law with respect to the treatment of customer data."

404 Media's Jason Koebler notes that "there's no way of knowing who is going to buy it, why they will be interested, and what will become of its millions of customers' DNA sequences. 23andMe has claimed over the years that it strongly resists law enforcement requests for information and that it takes customer security seriously. But the company has in recent years changed its terms of service, partnered with big pharmaceutical companies, and, of course, was hacked."

CERN faces a pivotal decision about its future as the Large Hadron Collider approaches the end of its usefulness by the early 2040s. Management proposes building the Future Circular Collider (FCC), a machine with a 90-kilometer circumference that would smash particles at eight times the energy of the LHC. This hugely consequential plan faces significant challenges. Much of the required technology doesn't exist yet, including superconducting magnets strong enough to bend high-energy particle beams.

The project also lacks the clear rationale that the LHC had in finding the Higgs boson. The proposal has divided physicists. Critics worry about the decades-long timeline, potential cost overruns, and the risk of sacrificing other valuable CERN activities. Germany, which provides 20% of the lab's budget, has already indicated it won't increase contributions. A council-appointed group is now gathering input from the physics community before making recommendations in December.

Nature's editorial board adds: Unless some nations step up with a major infusion of cash, the FCC faces an uncertain prospect of being funded. But waiting too long could mean that there will be a large gap between the new facility opening and the closure of the LHC, and precious expertise could end up being lost.

Although physicists might disagree on what CERN should do, they nearly unanimously care about the lab's future. They and their leaders must now make the case for why European taxpayers, who fund most of the lab's yearly budget should care, too. The stakes are beyond science, and even beyond Europe.

Scientists are developing biomarkers to objectively measure pain, addressing a fundamental medical challenge that has contributed to the opioid crisis and led to consistent underestimation of pain in women and minorities.

Four research teams funded by the Department of Health and Human Services are developing technologies to quantify pain like other vital signs. Their approaches include a blood test for endometriosis pain, a device measuring nerve response through pupil dilation, microneedle patches sampling interstitial fluid, and a wearable sensor detecting pain markers in sweat.

"When patients are told that the pain is all in their head, the implication is that it's imagined, but the irony is that's sort of right," said Adam Kepecs, a neuroscience professor at Washington University. "The pain only exists in your brain. It's neural activity, which is why it's invisible and uniquely personal. But it's still real." These innovations could transform treatment for the nearly 25% of Americans suffering from chronic pain, while potentially saving billions in healthcare costs.

RockDoctor (Slashdot reader #15,477) writes: A recent paper on ArXiv reports a novel idea about the central regions of "our" galaxy.

Remember the hoopla a few years ago about radio-astronomical observations producing an "image" of our central black hole — or rather, an image of the accretion disc around the black hole — long designated by astronomers as "Sagittarius A*" (or SGR-A*)? If you remember the image published then, one thing should be striking — it's not very symmetrical. If you think about viewing a spinning object, then you'd expect to see something with a "mirror" symmetry plane where we would see the rotation axis (if someone had marked it). If anything, that published image has three bright spots on a fainter ring. And the spots are not even approximately the same brightness.

This paper suggests that the image we see is the result of the light (radio waves) from SGR-A* being "lensed" by another black hole, near (but not quite on) the line of sight between SGR-A* and us. By various modelling approaches, they then refine this idea to a "best-fit" of a black hole with mass around 1000 times the Sun, orbiting between the distance of the closest-observed star to SGR-A* ("S2" — most imaginative name, ever!), and around 10 times that distance. That's far enough to make a strong interaction with "S2" unlikely within the lifetime of S2 before it's accretion onto SGR-A*.)

The region around SGR-A* is crowded. Within 25 parsecs (~80 light years, the distance to Regulus [in the constellation Leo] or Merak [in the Great Bear]) there is around 4 times more mass in several millions of "normal" stars than in the SGR-A* black hole. Finding a large (not "super massive") black hole in such a concentration of matter shouldn't surprise anyone.

This proposed black hole is larger than anything which has been detected by gravitational waves (yet) ; but not immensely larger — only a factor of 15 or so. (The authors also anticipate the "what about these big black holes spiralling together?" question : quote "and the amplitude of gravitational waves generated by the binary black holes is negligible.")

Being so close to SGR-A*, the proposed black hole is likely to be moving rapidly across our line of sight. At the distance of "S2" it's orbital period would be around 26 years (but the "new" black hole is probably further out than than that). Which might be an explanation for some of the variability and "flickering" reported for SGR-A* ever since it's discovery.

As always, more observations are needed. Which, for SGR-A* are frequently being taken, so improving (or ruling out) this explanation should happen fairly quickly. But it's a very interesting, and fun, idea.

NPR reports on research "into whether our defenses built up from past flu seasons can offer any protection against H5N1 bird flu." So far, the findings offer some reassurance. Antibodies and other players in the immune system may buffer the worst consequences of bird flu, at least to some degree. "There's certainly preexisting immunity," says Florian Krammer, a virologist at Mount Sinai's Icahn School of Medicine who is involved in some of the new studies. "That's very likely not going to protect us as a population from a new pandemic, but it might give us some protection against severe disease." This protection is based on shared traits between bird flu and types of seasonal flu that have circulated among us. Certain segments of the population, namely older people, may be particularly well-primed because of flu infections during early childhood.

Of course, there are caveats. "While this is a bit of a silver lining, it doesn't mean we should all feel safe," says Seema Lakdawala, a virologist at Emory University's School of Medicine whose lab is probing this question. For one thing, the studies can't be done on people. The conclusions are based on animal models and blood tests that measure the immune response. And how this holds up for an individual is expected to vary considerably, depending on their own immune history, underlying health conditions and other factors. But for now, influenza researchers speculate this may be one reason most people who've caught bird flu over the past year have not fallen severely ill....

Research published this month is encouraging. By analyzing blood samples from close to 160 people, a team at the University of Pennsylvania and the University of Chicago were able to show that people born roughly before 1965 had higher levels of antibodies — proteins that bind to parts of the virus — which cross-react to the current strain of bird flu.
This week U.S. federal officials also "announced funding for avian influenza research projects, including money for new vaccine projects and potential treatments," the Guardian report. The head of America's agriculture department said it would invest $100 million, as part of a larger $1 billion initiative to fight bird flu and stop rising egg prices, according to the nonprofit news site Iowa Capital Dispatch.